These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3669004)

  • 1. Synthesis and gastrointestinal pharmacology of the 4-fluoro analogue of enisoprost.
    Collins PW; Kramer SW; Gullikson GW
    J Med Chem; 1987 Nov; 30(11):1952-5. PubMed ID: 3669004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18-cycloalkyl analogues of enisoprost.
    Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF
    J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of acyclic omega chain conjugated diene analogues of enisoprost.
    Collins PW; Shone RL; Perkins WE; Gasiecki AF; Kalish VJ; Kramer SW; Bianchi RG
    J Med Chem; 1992 Feb; 35(4):694-704. PubMed ID: 1542096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour intragastric measurements in twenty healthy subjects: effect of enisoprost, a novel and potent antisecretory and antipeptic synthetic E1 prostaglandin.
    Thomson AB; McCullough HN; Kirdeikis P; Zuk L; Simpson I; Cook DJ; Wildeman RA; Brunet K; Fisher D; Pinchbeck B
    Aliment Pharmacol Ther; 1988 Aug; 2(4):325-36. PubMed ID: 2979255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha chain unsaturated derivatives of misoprostol.
    Collins PW; Gasiecki AF; Weier RM; Kramer SW; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
    Prostaglandins; 1987; 33 Suppl():17-28. PubMed ID: 3122273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
    Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
    Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and therapeutic role of synthetic prostaglandins in peptic ulcer disease.
    Collins PW
    J Med Chem; 1986 Apr; 29(4):437-43. PubMed ID: 3514911
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analogues.
    Kaminski JJ; Hilbert JM; Pramanik BN; Solomon DM; Conn DJ; Rizvi RK; Elliott AJ; Guzik H; Lovey RG; Domalski MS
    J Med Chem; 1987 Nov; 30(11):2031-46. PubMed ID: 3669011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and structure-activity relationships of C-17 unsaturated 18-cycloalkyl and cycloalkenyl analogues of enisoprost. Identification of a promising new antiulcer prostaglandin.
    Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Bianchi RG; Kramer SW; Ng JS; Yonan EE; Swenton L; Jones PH
    J Med Chem; 1990 Oct; 33(10):2784-93. PubMed ID: 2213831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of benzindene prostaglandins: novel potent antiulcer agents.
    Aristoff PA; Harrison AW; Johnson PD; Robert A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():275-7. PubMed ID: 2936104
    [No Abstract]   [Full Text] [Related]  

  • 13. The synthesis of 13-cis-dl-erythro-15,16-dihydroxyprostaglandins.
    Bornatsch W; Untch KG
    Prostaglandins; 1977 Oct; 14(4):617-23. PubMed ID: 594366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and gastric mucosal protection by esaprazole in rats.
    Zuccari G; Clavenna G; Sala A; Viganò T; Crivellari MT; Folco G
    Eur J Pharmacol; 1990 Oct; 187(1):19-25. PubMed ID: 2272352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Condensed thienopyrimidines. I. Synthesis and gastric antisecretory activity of 2,3-dihydro-5H-oxazolothienopyrimidin-5-one derivatives.
    Sugiyama M; Sakamoto T; Tabata K; Endo K; Ito K; Kobayashi M; Fukumi H
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2091-102. PubMed ID: 2598309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal protective activity of prostaglandin analogs in rodent colonic inflammation.
    Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gasiecki AF; Collins PW
    Inflammation; 1992 Dec; 16(6):623-9. PubMed ID: 1334049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and gastric antisecretory properties of alpha chain diene derivatives of misoprostol.
    Collins PW; Gasiecki AF; Jones PH; Bauer RF; Gullikson GW; Woods EM; Bianchi RG
    J Med Chem; 1986 Jul; 29(7):1195-201. PubMed ID: 3100795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
    Perkins WE; Burton EG; Tsai BS; Collins PW; Casler JJ; Gasiecki AF; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1004-7. PubMed ID: 1762057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiulcer agents. II. Synthesis and gastric acid antisecretory activity of N-[3-(3-(piperidinomethyl)phenoxy)propyl]-4-(1-methyl-1H- tetrazol-5-ylthio)butanamide and related compounds.
    Ueda I; Ishii K; Sinozaki K; Seiki M; Hatanaka M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1430-5. PubMed ID: 1934163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiulcer activity of N-substituted N'-[3-[3-(piperidinomethyl)phenoxy]propyl]ureas: histamine H2-receptor antagonists with a potent mucosal protective activity.
    Miyashita M; Matsumoto T; Matsukubo H; Iinuma F; Taga F; Sekiguchi H; Hamada K; Okamura K; Nishino K
    J Med Chem; 1992 Jun; 35(13):2446-51. PubMed ID: 1352351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.